2022 Bioautomation Challenge: Investing in Automating Protein Engineering Thomas Kalil, Chief Innovation Officer of Schmidt Futures, interviews biomedical engineer Erika DeBenedictis Schmidt Futures is supporting an initiative – the 2022…
2022 Bioautomation Challenge: Investing in Automating Protein Engineering Thomas Kalil, Chief Innovation Officer of Schmidt Futures, interviews biomedical engineer Erika DeBenedictis Schmidt Futures is supporting an initiative – the 2022…
Recently, I caught up with Martin Borch Jensen, the Chief Science Officer of the biotech company Gordian Biotechnology. Gordian is a therapeutics company focused on the diseases of aging. Martin did…
Overuse of non-disclosure agreements (NDAs) is a pervasive problem in the United States. Companies apply these silencing tools to prevent their workers from sharing critical information with one another and…
As part of its American Pandemic Preparedness plan, the Biden Administration should establish an interagency working group (IWG) focused exclusively on the design, funding, and implementation of advance market commitments (AMCs)…